 | • レポートコード：D0804-05938 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、133ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、デシタビンの世界市場を広く調査・分析し、今後の市場展望をまとめております。デシタビンの種類別市場規模（10mg剤形、15mg剤形、25mg剤形）、用途別市場規模（プライマリMDS、セカンダリMDS）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson、Sun Pharmaceutical、Otsuka Pharmaceutical、Eli Lilly and Company、Accord Healthcare、Pharmachemie B.V.、Lupin、Dr Reddy's Laboratories、Sandoz、Cipla、Jiangsu Haosen Pharmaceutical Group、Lianyungang Runzhong Pharmaceutical、Shandong Xinshidai Pharmaceutical、Lianyungang Jierui Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、Qilu Pharmaceutical Hainan、ZHENGDA Tianqing Pharmaceutical Group ・地域別グローバル市場分析 2015年-2020年 ・デシタビンの北米市場（アメリカ、カナダ、メキシコ） ・デシタビンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・デシタビンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・デシタビンの南米市場（ブラジル、アルゼンチン） ・デシタビンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：10mg剤形、15mg剤形、25mg剤形 ・用途別分析：プライマリMDS、セカンダリMDS ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Decitabine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Decitabine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Decitabine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Decitabine market has been segmented into
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
By Application, Decitabine has been segmented into:
Primary MDS
Secondary MDS
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Decitabine market presented in the report. This section sheds light on the sales growth of different regional and country-level Decitabine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Decitabine market.
The report offers in-depth assessment of the growth and other aspects of the Decitabine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Decitabine Market Share Analysis
Decitabine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Decitabine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Decitabine sales, revenue and market share for each player covered in this report.
The major players covered in Decitabine are:
Johnson & Johnson
Sun Pharmaceutical
Otsuka Pharmaceutical
Eli Lilly and Company
Accord Healthcare
Pharmachemie B.V.
Lupin
Dr Reddy’s Laboratories
Sandoz
Cipla
Jiangsu Haosen Pharmaceutical Group
Lianyungang Runzhong Pharmaceutical
Shandong Xinshidai Pharmaceutical
Lianyungang Jierui Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
Qilu Pharmaceutical Hainan
ZHENGDA Tianqing Pharmaceutical Group
Among other players domestic and global, Decitabine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Decitabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Decitabine, with price, sales, revenue and global market share of Decitabine in 2018 and 2019.
Chapter 3, the Decitabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Decitabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Decitabine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Decitabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Decitabine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Decitabine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Decitabine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Overview of Global Decitabine Market
1.4.1 Global Decitabine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sun Pharmaceutical SWOT Analysis
2.2.4 Sun Pharmaceutical Product and Services
2.2.5 Sun Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Otsuka Pharmaceutical
2.3.1 Otsuka Pharmaceutical Details
2.3.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Otsuka Pharmaceutical SWOT Analysis
2.3.4 Otsuka Pharmaceutical Product and Services
2.3.5 Otsuka Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Accord Healthcare
2.5.1 Accord Healthcare Details
2.5.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Accord Healthcare SWOT Analysis
2.5.4 Accord Healthcare Product and Services
2.5.5 Accord Healthcare Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pharmachemie B.V.
2.6.1 Pharmachemie B.V. Details
2.6.2 Pharmachemie B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pharmachemie B.V. SWOT Analysis
2.6.4 Pharmachemie B.V. Product and Services
2.6.5 Pharmachemie B.V. Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lupin SWOT Analysis
2.7.4 Lupin Product and Services
2.7.5 Lupin Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dr Reddy’s Laboratories
2.8.1 Dr Reddy’s Laboratories Details
2.8.2 Dr Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dr Reddy’s Laboratories SWOT Analysis
2.8.4 Dr Reddy’s Laboratories Product and Services
2.8.5 Dr Reddy’s Laboratories Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sandoz
2.9.1 Sandoz Details
2.9.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sandoz SWOT Analysis
2.9.4 Sandoz Product and Services
2.9.5 Sandoz Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cipla SWOT Analysis
2.10.4 Cipla Product and Services
2.10.5 Cipla Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Jiangsu Haosen Pharmaceutical Group
2.11.1 Jiangsu Haosen Pharmaceutical Group Details
2.11.2 Jiangsu Haosen Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Jiangsu Haosen Pharmaceutical Group SWOT Analysis
2.11.4 Jiangsu Haosen Pharmaceutical Group Product and Services
2.11.5 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Lianyungang Runzhong Pharmaceutical
2.12.1 Lianyungang Runzhong Pharmaceutical Details
2.12.2 Lianyungang Runzhong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Lianyungang Runzhong Pharmaceutical SWOT Analysis
2.12.4 Lianyungang Runzhong Pharmaceutical Product and Services
2.12.5 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Shandong Xinshidai Pharmaceutical
2.13.1 Shandong Xinshidai Pharmaceutical Details
2.13.2 Shandong Xinshidai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Shandong Xinshidai Pharmaceutical SWOT Analysis
2.13.4 Shandong Xinshidai Pharmaceutical Product and Services
2.13.5 Shandong Xinshidai Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Lianyungang Jierui Pharmaceutical
2.14.1 Lianyungang Jierui Pharmaceutical Details
2.14.2 Lianyungang Jierui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Lianyungang Jierui Pharmaceutical SWOT Analysis
2.14.4 Lianyungang Jierui Pharmaceutical Product and Services
2.14.5 Lianyungang Jierui Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Jiangsu Aosaikang Pharmaceutical
2.15.1 Jiangsu Aosaikang Pharmaceutical Details
2.15.2 Jiangsu Aosaikang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Jiangsu Aosaikang Pharmaceutical SWOT Analysis
2.15.4 Jiangsu Aosaikang Pharmaceutical Product and Services
2.15.5 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Hangzhou Zhongmei Huadong Pharmaceutical
2.16.1 Hangzhou Zhongmei Huadong Pharmaceutical Details
2.16.2 Hangzhou Zhongmei Huadong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Hangzhou Zhongmei Huadong Pharmaceutical SWOT Analysis
2.16.4 Hangzhou Zhongmei Huadong Pharmaceutical Product and Services
2.16.5 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Qilu Pharmaceutical Hainan
2.17.1 Qilu Pharmaceutical Hainan Details
2.17.2 Qilu Pharmaceutical Hainan Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Qilu Pharmaceutical Hainan SWOT Analysis
2.17.4 Qilu Pharmaceutical Hainan Product and Services
2.17.5 Qilu Pharmaceutical Hainan Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 ZHENGDA Tianqing Pharmaceutical Group
2.18.1 ZHENGDA Tianqing Pharmaceutical Group Details
2.18.2 ZHENGDA Tianqing Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 ZHENGDA Tianqing Pharmaceutical Group SWOT Analysis
2.18.4 ZHENGDA Tianqing Pharmaceutical Group Product and Services
2.18.5 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Decitabine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Decitabine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Decitabine Manufacturer Market Share in 2019
3.3.2 Top 6 Decitabine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Decitabine Sales, Revenue and Market Share by Regions
4.1.1 Global Decitabine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Decitabine Revenue and Market Share by Regions (2015-2020)
4.2 North America Decitabine Sales and Growth Rate (2015-2020)
4.3 Europe Decitabine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Decitabine Sales and Growth Rate (2015-2020)
4.5 South America Decitabine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Decitabine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Decitabine Sales, Revenue and Market Share by Country
5.1.1 North America Decitabine Sales and Market Share by Country (2015-2020)
5.1.2 North America Decitabine Revenue and Market Share by Country (2015-2020)
5.2 United States Decitabine Sales and Growth Rate (2015-2020)
5.3 Canada Decitabine Sales and Growth Rate (2015-2020)
5.4 Mexico Decitabine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Decitabine Sales, Revenue and Market Share by Country
6.1.1 Europe Decitabine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Decitabine Revenue and Market Share by Country (2015-2020)
6.2 Germany Decitabine Sales and Growth Rate (2015-2020)
6.3 UK Decitabine Sales and Growth Rate (2015-2020)
6.4 France Decitabine Sales and Growth Rate (2015-2020)
6.5 Russia Decitabine Sales and Growth Rate (2015-2020)
6.6 Italy Decitabine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Decitabine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Decitabine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Decitabine Revenue and Market Share by Regions (2015-2020)
7.2 China Decitabine Sales and Growth Rate (2015-2020)
7.3 Japan Decitabine Sales and Growth Rate (2015-2020)
7.4 Korea Decitabine Sales and Growth Rate (2015-2020)
7.5 India Decitabine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Decitabine Sales and Growth Rate (2015-2020)
7.7 Australia Decitabine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Decitabine Sales, Revenue and Market Share by Country
8.1.1 South America Decitabine Sales and Market Share by Country (2015-2020)
8.1.2 South America Decitabine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Decitabine Sales and Growth Rate (2015-2020)
8.3 Argentina Decitabine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Decitabine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Decitabine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Decitabine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Decitabine Sales and Growth Rate (2015-2020)
9.3 Turkey Decitabine Sales and Growth Rate (2015-2020)
9.4 Egypt Decitabine Sales and Growth Rate (2015-2020)
9.5 South Africa Decitabine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Decitabine Sales and Market Share by Type (2015-2020)
10.2 Global Decitabine Revenue and Market Share by Type (2015-2020)
10.3 Global Decitabine Price by Type (2015-2020)
11 Global Decitabine Market Segment by Application
11.1 Global Decitabine Sales Market Share by Application (2015-2020)
11.2 Global Decitabine Revenue Market Share by Application (2015-2020)
11.3 Global Decitabine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Decitabine Sales, Revenue and Growth Rate (2021-2025)
12.2 Decitabine Market Forecast by Regions (2021-2025)
12.2.1 North America Decitabine Market Forecast (2021-2025)
12.2.2 Europe Decitabine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Decitabine Market Forecast (2021-2025)
12.2.4 South America Decitabine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Decitabine Market Forecast (2021-2025)
12.3 Decitabine Market Forecast by Type (2021-2025)
12.3.1 Global Decitabine Sales Forecast by Type (2021-2025)
12.3.2 Global Decitabine Market Share Forecast by Type (2021-2025)
12.4 Decitabine Market Forecast by Application (2021-2025)
12.4.1 Global Decitabine Sales Forecast by Application (2021-2025)
12.4.2 Global Decitabine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Decitabine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Decitabine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Decitabine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Decitabine Major Business
Table 9. Johnson & Johnson Decitabine Total Revenue (USD Million) (2018-2019)
Table 10. Johnson & Johnson SWOT Analysis
Table 11. Johnson & Johnson Decitabine Product and Services
Table 12. Johnson & Johnson Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceutical Decitabine Major Business
Table 15. Sun Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 16. Sun Pharmaceutical SWOT Analysis
Table 17. Sun Pharmaceutical Decitabine Product and Services
Table 18. Sun Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Otsuka Pharmaceutical Decitabine Major Business
Table 21. Otsuka Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 22. Otsuka Pharmaceutical SWOT Analysis
Table 23. Otsuka Pharmaceutical Decitabine Product and Services
Table 24. Otsuka Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company Decitabine Major Business
Table 27. Eli Lilly and Company Decitabine Total Revenue (USD Million) (2018-2019)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company Decitabine Product and Services
Table 30. Eli Lilly and Company Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. Accord Healthcare Decitabine Major Business
Table 33. Accord Healthcare Decitabine Total Revenue (USD Million) (2018-2019)
Table 34. Accord Healthcare SWOT Analysis
Table 35. Accord Healthcare Decitabine Product and Services
Table 36. Accord Healthcare Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pharmachemie B.V. Basic Information, Manufacturing Base and Competitors
Table 38. Pharmachemie B.V. Decitabine Major Business
Table 39. Pharmachemie B.V. Decitabine Total Revenue (USD Million) (2018-2019)
Table 40. Pharmachemie B.V. SWOT Analysis
Table 41. Pharmachemie B.V. Decitabine Product and Services
Table 42. Pharmachemie B.V. Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Decitabine Major Business
Table 45. Lupin Decitabine Total Revenue (USD Million) (2018-2019)
Table 46. Lupin SWOT Analysis
Table 47. Lupin Decitabine Product and Services
Table 48. Lupin Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 50. Dr Reddy's Laboratories Decitabine Major Business
Table 51. Dr Reddy's Laboratories Decitabine Total Revenue (USD Million) (2018-2019)
Table 52. Dr Reddy's Laboratories SWOT Analysis
Table 53. Dr Reddy's Laboratories Decitabine Product and Services
Table 54. Dr Reddy's Laboratories Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sandoz Basic Information, Manufacturing Base and Competitors
Table 56. Sandoz Decitabine Major Business
Table 57. Sandoz Decitabine Total Revenue (USD Million) (2018-2019)
Table 58. Sandoz SWOT Analysis
Table 59. Sandoz Decitabine Product and Services
Table 60. Sandoz Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Cipla Basic Information, Manufacturing Base and Competitors
Table 62. Cipla Decitabine Major Business
Table 63. Cipla Decitabine Total Revenue (USD Million) (2018-2019)
Table 64. Cipla SWOT Analysis
Table 65. Cipla Decitabine Product and Services
Table 66. Cipla Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Jiangsu Haosen Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 68. Jiangsu Haosen Pharmaceutical Group Decitabine Major Business
Table 69. Jiangsu Haosen Pharmaceutical Group Decitabine Total Revenue (USD Million) (2018-2019)
Table 70. Jiangsu Haosen Pharmaceutical Group SWOT Analysis
Table 71. Jiangsu Haosen Pharmaceutical Group Decitabine Product and Services
Table 72. Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Lianyungang Runzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Lianyungang Runzhong Pharmaceutical Decitabine Major Business
Table 75. Lianyungang Runzhong Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 76. Lianyungang Runzhong Pharmaceutical SWOT Analysis
Table 77. Lianyungang Runzhong Pharmaceutical Decitabine Product and Services
Table 78. Lianyungang Runzhong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Shandong Xinshidai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Shandong Xinshidai Pharmaceutical Decitabine Major Business
Table 81. Shandong Xinshidai Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 82. Shandong Xinshidai Pharmaceutical SWOT Analysis
Table 83. Shandong Xinshidai Pharmaceutical Decitabine Product and Services
Table 84. Shandong Xinshidai Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Lianyungang Jierui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Lianyungang Jierui Pharmaceutical Decitabine Major Business
Table 87. Lianyungang Jierui Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 88. Lianyungang Jierui Pharmaceutical SWOT Analysis
Table 89. Lianyungang Jierui Pharmaceutical Decitabine Product and Services
Table 90. Lianyungang Jierui Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Jiangsu Aosaikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Jiangsu Aosaikang Pharmaceutical Decitabine Major Business
Table 93. Jiangsu Aosaikang Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 94. Jiangsu Aosaikang Pharmaceutical SWOT Analysis
Table 95. Jiangsu Aosaikang Pharmaceutical Decitabine Product and Services
Table 96. Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Major Business
Table 99. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Total Revenue (USD Million) (2018-2019)
Table 100. Hangzhou Zhongmei Huadong Pharmaceutical SWOT Analysis
Table 101. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product and Services
Table 102. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Qilu Pharmaceutical Hainan Basic Information, Manufacturing Base and Competitors
Table 104. Qilu Pharmaceutical Hainan Decitabine Major Business
Table 105. Qilu Pharmaceutical Hainan Decitabine Total Revenue (USD Million) (2018-2019)
Table 106. Qilu Pharmaceutical Hainan SWOT Analysis
Table 107. Qilu Pharmaceutical Hainan Decitabine Product and Services
Table 108. Qilu Pharmaceutical Hainan Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. ZHENGDA Tianqing Pharmaceutical Group Decitabine Type and Application
Table 110. ZHENGDA Tianqing Pharmaceutical Group Decitabine Major Business
Table 111. ZHENGDA Tianqing Pharmaceutical Group Decitabine Total Revenue (USD Million) (2018-2019)
Table 112. ZHENGDA Tianqing Pharmaceutical Group SWOT Analysis
Table 113. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product and Services
Table 114. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Decitabine Sales by Manufacturer (2018-2019) (K Units)
Table 116. Global Decitabine Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Decitabine Sales by Regions (2015-2020) (K Units)
Table 118. Global Decitabine Sales Market Share by Regions (2015-2020)
Table 119. Global Decitabine Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Decitabine Sales by Countries (2015-2020) (K Units)
Table 121. North America Decitabine Sales Market Share by Countries (2015-2020)
Table 122. North America Decitabine Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Decitabine Revenue Market Share by Countries (2015-2020)
Table 124. Europe Decitabine Sales by Countries (2015-2020) (K Units)
Table 125. Europe Decitabine Sales Market Share by Countries (2015-2020)
Table 126. Europe Decitabine Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Decitabine Sales by Regions (2015-2020) (K Units)
Table 128. Asia-Pacific Decitabine Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Decitabine Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Decitabine Sales by Countries (2015-2020) (K Units)
Table 131. South America Decitabine Sales Market Share by Countries (2015-2020)
Table 132. South America Decitabine Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Decitabine Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Decitabine Sales by Countries (2015-2020) (K Units)
Table 135. Middle East & Africa Decitabine Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Decitabine Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Decitabine Revenue Market Share by Countries (2015-2020)
Table 138. Global Decitabine Sales by Type (2015-2020) (K Units)
Table 139. Global Decitabine Sales Share by Type (2015-2020)
Table 140. Global Decitabine Revenue by Type (2015-2020) (USD Million)
Table 141. Global Decitabine Revenue Share by Type (2015-2020)
Table 142. Global Decitabine Sales by Application (2015-2020) (K Units)
Table 143. Global Decitabine Sales Share by Application (2015-2020)
Table 144. Global Decitabine Sales Forecast by Regions (2021-2025) (K Units)
Table 145. Global Decitabine Market Share Forecast by Regions (2021-2025)
Table 146. Global Decitabine Sales Forecast by Type (2021-2025) (K Units)
Table 147. Global Decitabine Market Share Forecast by Type (2021-2025)
Table 148. Global Decitabine Sales Forecast by Application (2021-2025)
Table 149. Global Decitabine Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Decitabine Picture
Figure 2. Global Sales Market Share of Decitabine by Type in 2019
Figure 3. 10 Mg Dosage Forms Picture
Figure 4. 15 Mg Dosage Forms Picture
Figure 5. 25 Mg Dosage Forms Picture
Figure 6. Decitabine Sales Market Share by Application in 2018
Figure 7. Primary MDS Picture
Figure 8. Secondary MDS Picture
Figure 9. Global Decitabine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Decitabine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Decitabine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Decitabine Sales Market Share by Manufacturer in 2019
Figure 30. Global Decitabine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Decitabine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Decitabine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Decitabine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Decitabine Revenue Market Share by Regions in 2018
Figure 38. North America Decitabine Sales and Growth Rate (2015-2020)
Figure 39. Europe Decitabine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Decitabine Sales and Growth Rate (2015-2020)
Figure 41. South America Decitabine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Decitabine Sales and Growth Rate (2015-2020)
Figure 43. North America Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Decitabine Sales Market Share by Countries (2015-2020)
Figure 45. North America Decitabine Sales Market Share by Countries in 2018
Figure 46. North America Decitabine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Decitabine Revenue Market Share by Countries in 2018
Figure 48. United States Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Decitabine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Decitabine Revenue Market Share by Countries in 2019
Figure 54. Germany Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Decitabine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Decitabine Revenue Market Share by Regions 2019
Figure 62. China Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Decitabine Sales Market Share by Countries in 2019
Figure 69. South America Decitabine Revenue Market Share by Countries in 2019
Figure 70. Brazil Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Decitabine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Decitabine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Decitabine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Decitabine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Decitabine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Decitabine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Decitabine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Decitabine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Decitabine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Decitabine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Decitabine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Decitabine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
経口固形製剤受託製造の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oral Solid Dosage Contract Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral…- マネキンディスプレイフォームの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mannequin Display Forms market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mannequin Display For…
- マネキンディスプレイフォームの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mannequin Display Forms market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mannequin Display For…
- ピラルビシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pirarubicin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pirarubicin market report provide…
- ピラルビシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pirarubicin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pirarubicin market report provide…